7th Diabetes Drug Discovery and Development Conference
23 Apr 2014 - 25 Apr 2014 - Cambridge, MA, USA
The International Diabetes Federation estimates that
more than 285 million people world-wide have diabetes and 438 million people
will have this disease within 20 years. Type 2 Diabetes Mellitus (T2DM)
accounts for more than 90% of all diabetes and is characterized by insulin
resistance combined with relatively reduced insulin secretion. The seven major
markets for diabetes are expected to grow to 35 billion in 10 years driven by
patient population expansion and novel therapies.
Come and join other diabetes experts at GTC’s 7th
Diabetes Drug Discovery and Development Conference and hear key thought-leader's opinions
to these questions and many more. This important meeting will be held on April 23-25, 2014 in Cambridge,
MA. The conference will bring together the leading experts on diabetes from
both industry and academia to discuss novel targets for diabetes, lessons to
learn from current and clinical drug development.